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The demand for a new social under-
standing of headache disorders can be
traced back over more than 30 years.
During that period it has become ever
more evident and pressing, meanwhile
giving birth to research with outstand-
ing results in epidemiology, nosogra-
phy, pathophysiology, genetics and
more, and generating innovative thera-
peutic molecules and refined diagnos-
tic means. Despite all of this, the weak
position of headache disorders within
the public health value scale, long
apparent to scientists in the field, to
physicians, to lay organisations and to
people affected by these disorders, has
for much of this time meant an
increasing disparity with other neuro-
logical disorders.
Headache disorders are a major clinical
problem, and should be a public health
priority. These truths cannot be dis-
missed; actions are required to stop this
progression of headache down a slip-
pery slope of belittling disregard [1].
For ten years, a different trend carrying
a new message has been taking shape.
Several forces behind this are dis-
cernible. One is the birth of the World
Headache Alliance, bringing together
many lay organisations worldwide into
cooperative actions, pursuing objec-
tives that go way beyond the national
or local boundaries of each. A mix of
lay and non-lay initiatives have
appeared [2], the World Health
Organization has taken note, and sig-
nalled its interest in introductory publi-
cations [3], and calls for action are
being directed at wide audiences [4].
The final destruction of the slippery
slope, at the bottom of which headache
disorders would be seen as trivial and
undeserving of medical care, has been
put within our reach by the launch and
expanding achievements of Lifting The
Burden (LTB), the Global Campaign to
Reduce the Burden of Headache
Worldwide [5]. LTB’s intense activity
in support of better information, of
political awareness, of epidemiological
studies to improve knowledge and
understanding of the burden of
headache, of university and primary-
care education of health-care
providers, and of better clinical man-
agement of headache, especially in pri-
mary care, has provided a sound con-
ceptual basis for the inclusion of
headache disorders in WHO’s new
publication,  Neurological Disorders:
Public Health Challenges [6], which,
in turn, gives headache disorders a new
cultural identity and social dignity.
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Epidemiology and burden of headache
The importance of headache disorders, particularly the pri-
mary forms, arises from their high prevalence, their diffu-
sion throughout all geographical areas, their duration (most
are life-long conditions) and their imposition of disability
and restricted participation upon those affected by them.
Many epidemiological studies show that, every year,
migraine alone affects more than 10% of the world’s adult
population, whilst all headache disorders together affect
50% of the world’s adults and children [7]. Migraine is the
19th leading causes of disability in the world [8]. Other
headache disorders are probably responsible for at least as
much disability [7]; if this is confirmed, headache disorders
will be well within the top ten causes of disability, and
amongst the top five in women. This compelling evidence
constitutes the cornerstone of headache’s rebuilt image as a
major public health problem.
Artificial barriers to care
Social awareness goes hand in hand with political and man-
agerial responsiveness. Both are needed to support struc-
tures fit for the purpose of meeting headache-related
healthcare needs, able to reduce the costs of headache dis-
orders and prevent their magnification, which is the result
of mistreatment. Better care, backed by appropriate health-
care policies and priority-setting, and by better medical
training programmes, can be expected to mitigate not only
the heavy direct damage that headache causes – to the lives
of patients, their families and colleagues – but also the very
large indirect losses in work productivity [9]. It does not
make economic sense to leave headache under-treated, and
it is not humane to do so.
Yet, characterisation of headache disorders by health pro-
fessionals as conditions of low importance, or by people
affected by them as “normal” (non-medical) experiences,
discourages sufferers from seeking medical care. Alarm,
leading eventually to consultation, arises when headache is
out of control – a situation that maintains unnecessary suf-
fering and makes management more difficult. Low levels of
consultation encourage low levels of healthcare provision,
and allocation of few resources, which in turn further dis-
courages consultation and engenders dissatisfaction when
consultation does occur. Anetwork of simple care structures,
evenly distributed throughout each community, with diag-
nostic and therapeutic abilities that are well within the scope
of primary care, is all that is required. What currently exists
falls well below this almost everywhere, often unacceptably
so even in developed countries, whereas the gap between
these and developing countries is incommensurably large.
These barriers to care are artificial. It is hard to understand
why they were ever there, and impossible to justify their
continued existence.
Education is the key
Lack of resources is a factor in under-treatment, but it is not
an explanation. The diffusion of triptans worldwide may be
slow because of their cost, but good headache management
is not achieved merely by prescribing triptans and is rarely
entirely dependent upon access to this class of drug.
Education is the central pillar of adequate care.
Communities of people with headache, their families,
physicians, other heath-care providers, health-care man-
agers and policy-makers all need to be educated about
headache disorders, establishing a permanent bond that
leads to an ideal therapeutic headache chain. Progress is
seen in several educational initiatives: for doctors, the
European Headache Federation summer schools, for exam-
ple, and, for specialists, the Masters degree programme in
Headache Medicine [10]. Education of people with
headache promotes appropriate consultation, which does
not happen at the moment. Education of health profession-
als minimises the risk of failed or delayed diagnosis, which
currently occurs too often. Prompt and accurate diagnosis
allows early therapeutic intervention with stepwise medical
management, first in primary care and then, only when nec-
essary, in specialist consultation. Follow-up, so often omit-
ted, is crucial to achieving a good outcome. Without that
comes self-treatment, in which lack of education raises the
probability of overuse of over-the-counter medications, and
worsening illness.
Public health policy
Managed change depends upon supportive policy. Research
in the headache area, always alive and rich in innovations,
should educate public health policy-makers. To do so, it
should be able to translate its findings into new and acces-
sible therapeutic approaches in a short time. The expansion
of epidemiologic research in headache, coupled with
health-economic analysis, will strengthen our certainties.
Meanwhile, the burdens imposed by headache disorders on
individuals and society are sufficiently evident to validate a
new public health strategy aimed at minimising their nega-
tive consequences. If good healthcare structures must be
created in countries worldwide, the necessity of equipping
them with medical professionals trained in headache at uni-
versity level is unquestionable. But equally necessary is151
recognition of need by those in control of healthcare
resource allocation.
WHO’s report [6] should leave no doubt in the minds of
healthcare policy-makers that headache disorders com-
mand their attention, and can no longer be regarded as sim-
ple inconveniences, undeserving of medical care. Lay
organisations and professional associations should march
together to insist on these requirements. LTB acts in this
area both as coordinator and a means of spreading innova-
tion [11].
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